During induction of puberty, clinical assessment of pubertal staging and adjustment of estrogen dose takes place every three months.

For adults on maintenance estrogen replacement therapy, assessment of withdrawal bleed pattern and overall well-being should be undertaken on an annual basis and assessment of bone density approximately every five years.

Routine audiologic assessment is appropriate in individuals who have hearing impairment or are at risk for Perrault syndrome, as hearing loss is often progressive in nature. Audiologic surveillance is not required in individuals with profound hearing loss.
